poisar

Stocks · News reference

Moderna Announces That Its MRNA-1403 Norovirus Vaccine Candidate Did Not Meet Statistical Criteria For Early Success At Phase 3 Interim Analysis; Now Preparing To Enroll An Additional Cohort

BenzingaJul 31, 2026, 11:26 AMBenzinga Newsdesk

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Jul 31, 2026, 11:26 AM
Checked
Jul 31, 2026, 11:26 AM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading